Stimulus functions of caffeine in humans: Relation to dependence potential

The interoceptive stimulus functions common to drugs of dependence include positive subjective effects, discriminative functions, and reinforcing functions. Data from studies measuring these stimulus functions constitute the objective assessment of a drug's dependence potential. This paper reviews the subjective effects, discriminative stimulus, and reinforcing stimulus functions of caffeine in humans to assess the dependence potential of caffeine. The stimulus effects of caffeine are compared with those of d-amphetamine, a prototypic CNS stimulant that has been studied under similar conditions, to evaluate the relative dependence potential of caffeine. Finally, caffeine's effects are evaluated in terms of generally accepted criteria for defining drug dependence. It is concluded that caffeine partially meets the primary criteria of drug dependence: 1) the majority of caffeine use is highly controlled, but not compulsive; 2) caffeine is psychoactive; and 3) caffeine functions as a reinforcer under certain conditions in humans, but not in animals. Caffeine thus has limited dependence potential. Additionally, although caffeine shares stimulus functions with d-amphetamine, it does so under limited conditions and should be considered to have a relatively lower dependence potential.

[1]  J. Rose Cigarette smoking blocks caffeine-induced arousal. , 1987, Alcohol and drug research.

[2]  J. Greden,et al.  Caffeine-withdrawal headache: a clinical profile. , 1980, Psychosomatics.

[3]  J. Henningfield,et al.  Human abuse liability assessment by measurement of subjective and physiological effects. , 1989, NIDA research monograph.

[4]  W K Bickel,et al.  Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. , 1991, Archives of general psychiatry.

[5]  J T Rainey Headache related to chronic caffeine addiction. , 1985, Texas dental journal.

[6]  S. Heishman,et al.  Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. , 1989, The Journal of pharmacology and experimental therapeutics.

[7]  T. Thompson,et al.  Predicting dependence liability of stimulant and depressant drugs , 1977 .

[8]  N. Back,et al.  Modern methods in pharmacology , 1982 .

[9]  F. Hoffmeister,et al.  Self-administration of acetylsalicylic acid and combinations with codeine and caffeine in rhesus monkeys. , 1973, The Journal of pharmacology and experimental therapeutics.

[10]  B K Tang,et al.  Variability in caffeine metabolism , 1983, Clinical pharmacology and therapeutics.

[11]  Winstead Dk,et al.  Coffee consumption among psychiatric inpatients. , 1976 .

[12]  J. Griffith Amphetamine Dependence; Clinical Features , 1977 .

[13]  M. Jc An overview: maternal nicotine and caffeine consumption and offspring outcome. , 1982 .

[14]  J. E. James,et al.  Caffeine: a survey of some of the known and suspected deleterious effects of habitual use. , 1983, British journal of addiction.

[15]  G. Edwards,et al.  Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. , 1981, Bulletin of the World Health Organization.

[16]  K. Preston,et al.  Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. , 1987, The Journal of pharmacology and experimental therapeutics.

[17]  J. Sours,et al.  Case reports of anorexia nervosa and caffeinism. , 1983, The American journal of psychiatry.

[18]  P. Gupta,et al.  Caffeine: a new look at an age-old drug. , 1988, International journal of clinical pharmacology, therapy, and toxicology.

[19]  D. Charney,et al.  The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. , 1984, Life sciences.

[20]  R. Griffiths,et al.  Opioids: Similarity between evaluations of subjective effects and animal self‐administration results , 1979, Clinical pharmacology and therapeutics.

[21]  A. Goldstein,et al.  PSYCHOTROPIC EFFECTS OF CAFFEINE IN MAN. I. INDIVIDUAL DIFFERENCES IN SENSITIVITY TO CAFFEINE-INDUCED WAKEFULNESS. , 1965, The Journal of pharmacology and experimental therapeutics.

[22]  J. Woods,et al.  Reinforcement Properties of Morphine, Cocaine, and SPA as a Function of Unit Dose , 1968 .

[23]  C. Schuster,et al.  Internal stimulus control and subjective effects of drugs. , 1981, NIDA research monograph.

[24]  N. Benowitz,et al.  Clinical pharmacology of caffeine. , 1990, Annual review of medicine.

[25]  R. S. Da Silva,et al.  Caffeine , 1984, Springer Berlin Heidelberg.

[26]  P. Rozin,et al.  Some aspects of the liking for hot coffee and coffee flavor , 1982, Appetite.

[27]  J. Garriott,et al.  Five cases of fatal overdose from caffeine-containing "look-alike" drugs. , 1985, Journal of analytical toxicology.

[28]  Roland R. Griffiths,et al.  Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans , 1987, Pharmacology Biochemistry and Behavior.

[29]  H. de Wit,et al.  Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. , 1986, Drug and alcohol dependence.

[30]  W. Watson,et al.  Caffeine withdrawal symptoms. , 1987, American Journal of Emergency Medicine.

[31]  A. Goldstein,et al.  Psychotropic effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives , 1969, Clinical pharmacology and therapeutics.

[32]  K. Gilliland,et al.  Caffeine: a potential drug of abuse. , 1984, Advances in alcohol & substance abuse.

[33]  R. M. Elliott,et al.  Behavior of Organisms , 1991 .

[34]  R. Griffiths,et al.  Low-dose caffeine physical dependence in humans. , 1990, The Journal of pharmacology and experimental therapeutics.

[35]  M. Lader,et al.  The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. , 1986, British journal of clinical pharmacology.

[36]  A. Goldstein,et al.  Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee , 1969, Clinical pharmacology and therapeutics.

[37]  R. Griffiths,et al.  Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. , 1986, The Journal of pharmacology and experimental therapeutics.

[38]  Rainey Jt Headache related to chronic caffeine addiction. , 1985 .

[39]  R. Griffiths,et al.  Relative abuse liability of triazolam: Experimental assessment in animals and humans , 1985, Neuroscience & Biobehavioral Reviews.

[40]  J. Greden,et al.  Anxiety and depression associated with caffeinism among psychiatric inpatients. , 1978, The American journal of psychiatry.

[41]  S. Evans,et al.  Amphetamine-like effects of anorectics and related compounds in pigeons. , 1987, The Journal of pharmacology and experimental therapeutics.

[42]  T. Rall Drugs used in the treatment of asthma , 1990 .

[43]  H. Cappell,et al.  Tolerance and Physical Dependence , 1981 .

[44]  C. Haertzen An Overview of Addiction Research Center Inventory Scales (ARCI): An Appendix and Manual of Scales. , 1974 .

[45]  M. Mattila,et al.  Caffeine and theophylline counteract diazepam effects in man. , 1983, Medical biology.

[46]  M. Enslen,et al.  Self-administration of caffeine by the rat. , 1976, Arzneimittel-Forschung.

[47]  E. O. O. Smoking "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Title Page through Table of Contents) , 1988 .

[48]  R. Griffiths,et al.  Effects of caffeine on cigarette smoking and subjective response , 1983, Clinical pharmacology and therapeutics.

[49]  J. Henningfield,et al.  Abuse liability assessment in human subjects , 1984 .

[50]  R. LaBrie,et al.  Assessing the subjective effects of stimulants in casual users; A methodology and preliminary results , 1978, Clinical pharmacology and therapeutics.

[51]  E. Uhlenhuth,et al.  Drug preference and mood in humans: Repeated assessment of d-amphetamine , 1981, Pharmacology Biochemistry and Behavior.

[52]  S. File,et al.  Behavioral effects of acute and chronic administration of caffeine in the rat , 1988, Pharmacology Biochemistry and Behavior.

[53]  Myung Cw,et al.  Drug addiction and drug abuse in Korea. , 1974 .

[54]  W. Martin,et al.  Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test. , 1961, The Journal of pharmacology and experimental therapeutics.

[55]  R. Smith,et al.  CAFFEINE WITHDRAWAL HEADACHE , 1976, Journal of clinical pharmacy and therapeutics.

[56]  L. Kozlowski,et al.  Effect of caffeine on coffee drinking , 1976, Nature.

[57]  J. Brady,et al.  Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc. , 1984, NIDA research monograph.

[58]  S. Heishman,et al.  Discriminative stimulus effects of d-amphetamine, methylphenidate and diazepam in humans , 1989, Pharmacology Biochemistry and Behavior.

[59]  Stephen G. Holtzman,et al.  Tolerance to behavioral effects of caffeine in rats , 1988, Pharmacology Biochemistry and Behavior.

[60]  P. Rozin,et al.  Conditioned opponent responses in human tolerance to caffeine , 1984 .

[61]  P. Morrow Caffeine toxicity: a case of child abuse by drug ingestion. , 1987, Journal of forensic sciences.

[62]  D. Jasinski,et al.  Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man , 1971, Clinical pharmacology and therapeutics.

[63]  R. Notari,et al.  Predicting Caffeine Plasma Concentrations Resulting from Consumption of Food or Beverages: A Simple Method and its Origin , 1988, Drug intelligence & clinical pharmacy.

[64]  D. Jasinski,et al.  Assessment of the Abuse Potentiality of Morphinelike Drugs (Methods Used in Man) , 1977 .

[65]  N. Russ,et al.  Abuse of caffeine in substance abusers. , 1988, The Journal of clinical psychiatry.

[66]  M B Katan,et al.  Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. , 1990, BMJ.

[67]  D. Galletly,et al.  DOES CAFFEINE WITHDRAWAL CONTRIBUTE TO POSTANAESTHETIC MORBIDITY? , 1989, The Lancet.

[68]  Miller Jl Caffeine, chocolate and withdrawal headaches. , 1960 .

[69]  S. Woods,et al.  Caffeine: Preferential consumption by rats , 1975, Pharmacology Biochemistry and Behavior.

[70]  J. Brady,et al.  Stimulus functions of drugs and the assessment of abuse liability , 1990 .

[71]  J. Brady,et al.  Instrumental Conditioning of Jugular Self-Infusion in the Rhesus Monkey , 1961, Science.

[72]  J. J. Barone,et al.  Human Consumption of Caffeine , 1984 .

[73]  L. Roller,et al.  CAFFEINISM: SUBJECTIVE QUANTITATIVE ASPECT OF WITHDRAWAL SYNDROME , 1981, The Medical journal of Australia.

[74]  A. Goldstein,et al.  Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood. , 1965, The Journal of pharmacology and experimental therapeutics.

[75]  A. W. Downs,et al.  TOLERANCE AND CROSS-TOLERANCE IN THE HUMAN SUBJECT TO THE DIURETIC EFFECT OF CAFFEINE, THEOBROMINE AND THEOPHYLLINE , 1928 .

[76]  L. Saxén,et al.  Coffee consumption during pregnancy and selected congenital malformations: a nationwide case-control study. , 1983, American journal of public health.

[77]  K. Bättig,et al.  The Physiological Effects of Coffee Consumption , 1985 .

[78]  J K Wilkin,et al.  The caffeine withdrawal flush: report of a case of "weekend flushing". , 1986, Military medicine.

[79]  J. Crosbie,et al.  Somatic and psychological health implications of heavy caffeine use. , 1987, British journal of addiction.

[80]  G. Spiller The Methylxanthine beverages and foods : chemistry, consumption, and health effects , 1984 .

[81]  H. Lieberman,et al.  The Effects of Caffeine and Aspirin on Mood and Performance , 1987, Journal of clinical psychopharmacology.

[82]  W. Taylor,et al.  CARBENOXOLONE AND GASTRIC SECRETION , 1975, The Lancet.

[83]  Roland R. Griffiths,et al.  Reinforcing effects of caffeine in humans , 1988, Pharmacology Biochemistry and Behavior.

[84]  S J Heishman,et al.  Low-dose caffeine discrimination in humans. , 1990, The Journal of pharmacology and experimental therapeutics.

[85]  A. Winsor,et al.  A study of the development of tolerance for caffeinated beverages. , 1933 .

[86]  J. R. Weeks,et al.  Experimental Morphine Addiction: Method for Automatic Intravenous Injections in Unrestrained Rats , 1962, Science.

[87]  Podboy Jw,et al.  Caffeine reduction and behavior change in the severely retarded. , 1977 .

[88]  D. Kirmer Caffeine use and abuse in psychiatric clients. , 1988, Journal of psychosocial nursing and mental health services.

[89]  R. Foxx,et al.  Behavioral treatment of caffeinism: reducing excessive coffee drinking. , 1979, Journal of applied behavior analysis.

[90]  R R Watson,et al.  The effects of caffeine on various body systems: a review. , 1987, Journal of the American Dietetic Association.

[91]  E. D. Kemble,et al.  Effects of food deprivation on caffeine consumption in male and female rats , 1986, Pharmacology Biochemistry and Behavior.

[92]  Susan J Wells,et al.  Caffeine: implications of recent research for clinical practice. , 1984, The American journal of orthopsychiatry.

[93]  S. Higgins,et al.  A Comment on Contemporary Definitions of Reinforcement as a Behavioral Process , 1985 .

[94]  I. Syed,et al.  The effects of caffeine. , 1976, Journal of the American Pharmaceutical Association.

[95]  J W Podboy,et al.  Caffeine reduction and behavior change in the severely retarded. , 1977, Mental retardation.

[96]  D Robertson,et al.  The health consequences of caffeine. , 1983, Annals of internal medicine.

[97]  M G Myers,et al.  Effects of caffeine on blood pressure. , 1988, Archives of internal medicine.

[98]  D. Overton Applications and Limitations of the Drug Discrimination Method for the Study Of Drug Abuse , 1987 .

[99]  J L Katz,et al.  Abuse liability of benzodiazepines. , 1987, Pharmacological reviews.

[100]  K. Unna,et al.  Effects of chronic administration of the amphetamines and other stimulants on behavior , 1968, Clinical pharmacology and therapeutics.

[101]  James T. Kuznicki,et al.  The effects of caffeine on caffeine users and non-users , 1986, Physiology & Behavior.

[102]  Michael A. Bozarth Methods of assessing the reinforcing properties of abused drugs , 1987 .

[103]  S. Holtzman Caffeine as a model drug of abuse. , 1990, Trends in pharmacological sciences.

[104]  P. Ruiz,et al.  Substance abuse : clinical problems and perspectives , 1982 .

[105]  B. Skinner,et al.  Science and human behavior , 1953 .

[106]  P. B. Dews,et al.  Behavioral effects of caffeine , 2020, Caffeine and Behavior: Current Views & Research Trends.

[107]  C. Haertzen,et al.  Addiction Research Center Inventory (ARCI): Measurement of Euphoria and Other Drug Effects , 1987 .

[108]  J. Carney,et al.  EFFECTS OF CAFFEINE, THEOPHYLLINE AND THEOBROMINE ON SCHEDULED CONTROLLED RESPONDING IN RATS , 1982, British journal of pharmacology.

[109]  J. McGowan,et al.  Neonatal Withdrawal Symptoms After Chronic Maternal Ingestion of Caffeine , 1988, Southern medical journal.

[110]  R Workman,et al.  Tolerance to the humoral and hemodynamic effects of caffeine in man. , 1981, The Journal of clinical investigation.

[111]  K. Preston,et al.  Subjective and discriminative effects of drugs. , 1991, Behavioural pharmacology.

[112]  H. Kalant,et al.  Drug policy: striking the right balance. , 1990, Science.

[113]  R. Griffiths,et al.  Predicting the Abuse Liability of Drugs with Animal Drug Self-Administration Procedures: Psychomotor Stimulants and Hallucinogens , 1979 .

[114]  J. Greden,et al.  Somatic manifestations of caffeinism. , 1981, The Journal of clinical psychiatry.

[115]  Roland R. Griffiths,et al.  Reinforcing properties of caffeine: Studies in humans and laboratory animals , 1988, Pharmacology Biochemistry and Behavior.

[116]  F. Holloway,et al.  Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. , 1985, Life sciences.

[117]  D E Grobbee,et al.  Coffee, caffeine, and cardiovascular disease in men. , 1990, The New England journal of medicine.

[118]  D. Gauvin,et al.  Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. , 1985, Life sciences.

[119]  M M Callahan,et al.  Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[120]  G. Friedman,et al.  Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. , 1990, American journal of epidemiology.

[121]  R. Edelmann,et al.  The Effects of Caffeine on Psychological Functioning , 1985, Nutrition and health.

[122]  S. File,et al.  Interaction Between Effects of Caffeine and Lorazepam in Performance Tests and Self‐Ratings , 1982, Journal of clinical psychopharmacology.

[123]  R. Griffiths,et al.  Human coffee drinking: manipulation of concentration and caffeine dose. , 1986, Journal of the experimental analysis of behavior.

[124]  A. Leviton Caffeine consumption and the risk of reproductive hazards. , 1988, The Journal of reproductive medicine.

[125]  M. Mattila,et al.  Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. , 1988, International clinical psychopharmacology.

[126]  R. Griffiths,et al.  Reinforcing effects of caffeine in coffee and capsules. , 1989, Journal of the experimental analysis of behavior.

[127]  Jaffe Jh,et al.  Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. , 1989 .

[128]  R. E. Gosselin,et al.  The tolerance of coffee drinkers to caffeine , 1968, Clinical pharmacology and therapeutics.

[129]  R. Noble A Controlled Clinical Trial of the Cardiovascular and Psychological Effects of Phenylpropanolamine and Caffeine , 1988, Drug intelligence & clinical pharmacy.

[130]  H. Reimann Caffeinism. A cause of long-continued, low-grade fever. , 1967, JAMA.

[131]  B. Hampton,et al.  Caffeine fading: Behavioral treatment of caffeine abuse , 1985 .

[132]  K Hirsh,et al.  Central nervous system pharmacology of the dietary methylxanthines. , 1984, Progress in clinical and biological research.

[133]  P. J. Abbott Caffeine: a toxicological overview , 1986, The Medical journal of Australia.

[134]  D. Templer,et al.  Effects of caffeine on anxiety and depression. , 1984, Journal of abnormal psychology.

[135]  J. Greden,et al.  Anxiety or caffeinism: a diagnostic dilemma. , 1974, The American journal of psychiatry.

[136]  B. Weiss,et al.  Enhancement of human performance by caffeine and the amphetamines. , 1962, Pharmacological reviews.

[137]  Margaret C. Mc Manamy,et al.  Caffeine Intoxication: Report of a Case the Symptoms of Which Amounted to a Psychosis , 1936 .

[138]  M. Fischman,et al.  Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs. , 1989, NIDA research monograph.